Ofatumumab versus Teriflunomide in Multiple Sclerosis

ASCLEPIOS I and ASCLEPIOS II Trial Groups, Andrejs Millers, Guntis Karelis

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Ofatumumab versus Teriflunomide in Multiple Sclerosis'. Together they form a unique fingerprint.

Medicine & Life Sciences